**Core Concept**
Malignant glaucoma is a rare, severe form of secondary glaucoma characterized by a shallow or flat anterior chamber, typically following cataract surgery or other ocular trauma. It is often associated with misdirected aqueous flow, leading to increased intraocular pressure (IOP) and potential vision loss.

**Why the Correct Answer is Right**
Malignant glaucoma results from misdirected aqueous flow, which can occur due to the formation of a posteriorly dislocated lens-iris diaphragm or the failure of the vitreous to collapse properly after cataract surgery. This misdirected flow leads to increased IOP and a shallow or flat anterior chamber. Atropine is often used in the management of malignant glaucoma as it helps to deepen the anterior chamber by dilating the pupils and increasing the pressure in the vitreous body.

**Why Each Wrong Option is Incorrect**
**Option A:** The statement that the anterior chamber is normal in malignant glaucoma is incorrect, as this condition is characterized by a shallow or flat anterior chamber.
**Option C:** Pilocarpine, a miotic agent, is not typically used in the treatment of malignant glaucoma as it can worsen the condition by increasing the pressure in the anterior chamber.
**Option D:** Management of malignant glaucoma is not limited to medical treatment only, as surgical interventions such as vitreoretinal surgery may be necessary to address the underlying cause of the condition.

**Clinical Pearl / High-Yield Fact**
Malignant glaucoma is a medical emergency that requires prompt recognition and treatment to prevent vision loss. It is essential to differentiate it from other forms of secondary glaucoma, such as uveitic glaucoma, which may require different management strategies.

**✓ Correct Answer: B. be. Atropine is also given.**